Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 202.51

-1.7%

3:24 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew H who wrote (10951)	11/12/1997 8:33:00 AM
From: Henry Niman	Read Replies (1) of 32384

Andy, Early last month the Daily Transcript also put out a summary of the oral Panretin treatment of APL: Allergan Trials Allergan Ligand Retinoid Therapeutics announced that leukemia patients participating in a clinical trial of oral Panretin attained complete durable remissions. The trial included 18 patients who were treated with a once-daily dose of the drug. Of the 18 patients, five were newly diagnosed and 13 were relapsed from previous therapy. Four of five newly diagnosed patients attained complete remission. The trail was conducted in the U.S. Allergan Ligand is a San Diego-based joint venture between Ligand Pharmaceuticals and Orange County-based Allergan.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next